Abrigoso, Cristina .

HRN: 22-45-38  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CEFUROXIME 1.5GM (VIAL)
01/04/2023
01/04/2023
IV
1.5 G
On Call To OR
For Stat Pelvic Lap
Waiting Final Action 
01/05/2023
CEFUROXIME 1.5GM (VIAL)
01/05/2023
01/06/2023
IV
1.5 G
Q8 X 3 Doses
S/P Pelvic Lap
Waiting Final Action 
01/05/2023
CEFUROXIME 500MG (TAB)
01/05/2023
01/11/2023
PO
1 Tab
BID
S/p Pelvic Lap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: